KOPRANNSEKopran Limited· PharmaceuticalsHighNeutral
Announced Thu, 4 Jun, 2026 · 22:28 IST

Kopran shareholders and creditors approve amalgamation scheme with Kopran Labs

Nclt Scheme FiledStrategic Transactions View source PDFExplain this filing

KOPRAN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+1.1%Reaction day
₹185.00
prior close
₹182.10
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.0%+1.1% vs market

On the reaction day the stock moved 1.1 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+1.0
10m
+0.5
15m
+1.0
30m
+2.0
Sessions after the filingfrom the prior close
StockMarketvs market
Reaction day
+1.1-0.0+1.1
Next day
-1.6-2.0+0.3
2d
-0.9-0.1-0.8
3d
-1.9-1.6-0.3
4d
-3.0-2.7-0.3
5d
-1.1+0.3-1.3
1w
-2.0+2.6-4.6
15d
+0.5+4.2-3.6
1m
+5.3+6.2-0.9
2m
+5.7+8.6-3.0
3m
+32.8+11.2+21.5
UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Kopran Limited shareholders, secured and unsecured creditors approved the Scheme of Amalgamation with Kopran Laboratories Limited (KLL) at NCLT-convened meetings on June 3, 2026. Equity shareholders voted 99.96 percent in favour (around 2.25 crore votes for vs 10,119 against). Public shareholders approved at 99.06 percent. The scheme now awaits final NCLT sanction.

Likely market impact

Scheme moves to NCLT for final approval. If sanctioned, KLL will merge into Kopran Limited, simplifying group structure.